ATE221785T1 - Verfahren zum selektiven methioninentzug für maligne säugetierzellen - Google Patents

Verfahren zum selektiven methioninentzug für maligne säugetierzellen

Info

Publication number
ATE221785T1
ATE221785T1 AT95906124T AT95906124T ATE221785T1 AT E221785 T1 ATE221785 T1 AT E221785T1 AT 95906124 T AT95906124 T AT 95906124T AT 95906124 T AT95906124 T AT 95906124T AT E221785 T1 ATE221785 T1 AT E221785T1
Authority
AT
Austria
Prior art keywords
methionine
mammal
malignant
withdrawal
mtase
Prior art date
Application number
AT95906124T
Other languages
English (en)
Inventor
Tsutomu Nobori
Dennis A Carson
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE221785T1 publication Critical patent/ATE221785T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AT95906124T 1993-12-29 1994-12-22 Verfahren zum selektiven methioninentzug für maligne säugetierzellen ATE221785T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/176,413 US5571510A (en) 1993-12-29 1993-12-29 Method for selective methionine starvation of malignant cells in mammals
PCT/US1994/014919 WO1995017908A1 (en) 1993-12-29 1994-12-22 Method for selective methionine starvation of malignant cells in mammals

Publications (1)

Publication Number Publication Date
ATE221785T1 true ATE221785T1 (de) 2002-08-15

Family

ID=22644262

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95906124T ATE221785T1 (de) 1993-12-29 1994-12-22 Verfahren zum selektiven methioninentzug für maligne säugetierzellen

Country Status (17)

Country Link
US (1) US5571510A (de)
EP (1) EP0805690B1 (de)
JP (1) JPH09507754A (de)
CN (1) CN1143325A (de)
AT (1) ATE221785T1 (de)
AU (1) AU694161B2 (de)
CA (1) CA2180262A1 (de)
CZ (1) CZ291281B6 (de)
DE (1) DE69431167T2 (de)
HU (1) HU221341B1 (de)
NO (1) NO962714L (de)
NZ (1) NZ278271A (de)
PL (1) PL182298B1 (de)
RO (1) RO117542B1 (de)
RU (1) RU2153885C2 (de)
TJ (1) TJ294B (de)
WO (1) WO1995017908A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461851B1 (en) 1992-11-19 2002-10-08 Anticancer, Inc. High expression modules containing two or more tandem copies of a methioninase encoding sequence
US5891704A (en) * 1992-11-19 1999-04-06 Anticancer, Inc. Method to produce high levels of methioninase
US6911309B2 (en) * 1993-12-29 2005-06-28 The Regents Of The University Of Californnia Nucleic acids encoding MTAse
US6870037B1 (en) * 1995-07-03 2005-03-22 Arch Development Corporation Methylthioadenosine phosphorylase compositions and methods of use in the diagnosis and treatment of proliferative disorders
US5861154A (en) * 1995-10-30 1999-01-19 Shionogi & Co., Ltd. Recombinant L-methionine γ-lyase
JP3375834B2 (ja) 1995-10-30 2003-02-10 塩野義製薬株式会社 組換えL−メチオニン γ−リアーゼ
WO2002020807A1 (fr) * 2000-09-05 2002-03-14 Shionogi & Co., Ltd. L-methionine $g(g)-lyase a fonction modifiee
US20030129262A1 (en) * 2001-08-30 2003-07-10 Epner Daniel E. Methionine restriction for cancer therapy
AU2003261354A1 (en) * 2002-08-02 2004-02-23 The Regents Of The University Of California New uses for inhibitors of inosine monophosphate dehydrogenase
CA2516191A1 (en) 2003-02-14 2004-09-02 Salmedix, Inc Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers
US20110002978A1 (en) * 2003-06-17 2011-01-06 Harrison Roger G Enzyme prodrug cancer therapy selectively targeted to tumor cells or tumor vasculature and methods of production and use thereof
RU2393866C2 (ru) * 2005-03-17 2010-07-10 Проекто Де Биомедисина Сима, С.Л. Применение 5'-метилтиоаденозина (мта) для предотвращения и/или лечения аутоиммунных заболеваний и/или отторжения трансплантата
WO2009032057A2 (en) 2007-08-29 2009-03-12 Adam Lubin Method for the selective therapy of disease
US8480731B2 (en) * 2008-04-14 2013-07-09 Medtronic ATS Medical, Inc. Tool for implantation of replacement heart valve
US9987241B2 (en) 2014-09-25 2018-06-05 The Board Of Regents Of The University Of Oklahoma Enzyme conjugate and prodrug cancer therapy
WO2020032951A1 (en) 2018-08-09 2020-02-13 The Board Of Regents Of The University Of Oklahoma Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US5122614A (en) * 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides

Also Published As

Publication number Publication date
NO962714L (no) 1996-08-26
DE69431167T2 (de) 2003-04-17
HU221341B1 (en) 2002-09-28
JPH09507754A (ja) 1997-08-12
RU2153885C2 (ru) 2000-08-10
WO1995017908A1 (en) 1995-07-06
RO117542B1 (ro) 2002-04-30
EP0805690A4 (de) 1999-05-12
CZ186996A3 (en) 1996-12-11
AU1445995A (en) 1995-07-17
TJ294B (en) 2001-03-30
PL182298B1 (pl) 2001-12-31
NZ278271A (en) 2001-07-27
AU694161B2 (en) 1998-07-16
EP0805690A1 (de) 1997-11-12
CA2180262A1 (en) 1995-07-06
EP0805690B1 (de) 2002-08-07
CN1143325A (zh) 1997-02-19
CZ291281B6 (cs) 2003-01-15
HUT75070A (en) 1997-04-28
HU9601695D0 (en) 1996-08-28
US5571510A (en) 1996-11-05
NO962714D0 (no) 1996-06-27
DE69431167D1 (de) 2002-09-12

Similar Documents

Publication Publication Date Title
DE69431167D1 (de) Verfahren zum selektiven methioninentzug für maligne säugetierzellen
ATE124694T1 (de) Chinazolinderivate um die antitumorwirkung zu verbessern.
MY103388A (en) Azithromycin and derivatives as antiprotozoal agents
GR3018029T3 (en) New protein-polycation conjugates.
IT8505193A0 (it) Giunto omocinetico ad ampia scorrevolezza, in particolare per il funzionamento ad alta velocita'.
AU6597981A (en) Drawer and slide
IT1238615B (it) Procedimento per l'arricchimento di polveri, risultanti nel cubilotto, con particelle metalliche
ES434934A1 (es) Perfeccionamientos en cierre de cremallera separables.
ES425462A1 (es) Perfeccionamientos en los aparatos para aplicar cursores de cierres de cremallera.
BE854580A (fr) Procede de soutenement d'excavations et de galeries, notamment dans l'industrie miniere et la construction de tunnels.
JPS5417580A (en) Apparatus for cleaning work lamp section
EP0309411A3 (de) Saccharid-Derivate
AU685022B2 (en) Native type II GAP, methods for purifying various GAPs and uses of GAPs to diagnose cancer
FR2311707A1 (fr) Carrosserie pour vehicule de transport de marchandises
IT8022232A0 (it) Tetto scorrevole rigido, in particolare di vetro, per un veicolo provvisto di un'apertura sul tetto.
USD259571S (en) Remote service conveyor unit
IT1177872B (it) Perfezionamento nella produzione di coke metallurgico
SU1625073A1 (ru) Устройство для компенсации температурного зазора между стыкуемыми элементами
AU6363486A (en) Promoter arrangement for streptomycetes vectors
PH23401A (en) Cancer cell combatting lymphocytes,process for the production thereof and anti-cancer agents,containing said lymphocytes
SE9100848L (sv) Kapell, avsett foeretraedesvis foer baatar
ES1000679U (es) Estuche porta-cintas de video
IT8248183A0 (it) Diagnostica con immonofluorescenza od immunoperossidasi su cellule di coltura infettate in vitro
ES1032031U (es) Soporte publicitario.
IT8384978A0 (it) Dispositivo atto alla visione nella direzione di marcia per corridori ciclisti.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties